期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖尿病心肌病的发病机制和干预研究进展 被引量：10

下载PDF
导出
摘要 糖尿病性心肌病（diabetic cardiomyopathy，DC）是糖尿病性心脏病的特异性病变．早在1972年．Ruber等人根据4个成年糖尿病（diabetes mellitus．DM）患者在无明显的冠状动脉及瓣膜病变、先天性心脏病、高血压及酗酒的情况下罹患充血性心衰首次提出DC的概念。迄今已有较多的证据表明，部分DM患者出现的心力衰竭与大血管的粥样硬化无关．而由DC所致。本文就DC的发病机制、心功能改变及干预治疗作一综述。
作者 丁帅 李宏亮 王凤林
机构地区 中日友好医院心血管外科 中日友好医院内分泌科
出处 《中日友好医院学报》 2008年第2期117-119,共3页 Journal of China-Japan Friendship Hospital
关键词 糖尿病心肌病 发病机制 糖尿病性心肌病 糖尿病性心脏病 先天性心脏病 瓣膜病变 充血性心衰 心功能改变
分类号 R587.1 [医药卫生—内分泌] R542.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1Asbun J,Villarreal FJ.The pathogenesis of myocardial fibrosis in the setting of diabetic cardimyopathy[JJ.Am Coll Cardio 2006,47:693-700.
  • 2Srikanthan P,Hsueh W.Preventing heart failure in patients with diabetes [J].Med Clin North Am,2004,88 (5):1237- 1256.
  • 3Wilson Tang WH,Maros A,Young JB.Ischemic heart disease and congestive heart failure in diabetic patients[J].Med Clin North Am, 2004, 88 (4) :1037-1061.
  • 4Unger RH.Lipotoxic diseases [J].Annu Rev Med,2002,53: 319-336.
  • 5Bell DS.Diabetic cardiomypahty [J].Diabetes Care,2003,26: 2791-2795.
  • 6Fioalaliso F, Bianchi R,Staszeawsky L, et al.Antioxidant treatment attenuates hyperglycemia -induced cardiomyocyte death in rats[J].J Mol Cell Cardiol 2004,37:959-968.
  • 7Golfman LS,Wilson CR, Shama S, et al.Activation of Ppargamma enhances myocardial glucose oxidation and improves contractile function in isolated Working hearts of ZDF rats [J].Am J Physiol Endocrinol Metab,2005,289: E328-E336.
  • 8蒋彬,周希平,蒋文平.钠-钙交换与慢性心力衰竭[J].心血管病学进展,2002,23(6):371-374. 被引量：7
  • 9Hiranandani N,Janssen PM,Bupha -Intra T,et al.SERCA overexpression reduces hydroxyl radical injury in murine myocardium [J].Am J Physiol Heart Cire Physiol,2006,291: H3130-H3135.
  • 10Qin D,Huang B,Deng L,et al.Downregulation of K+ channel genes expression in type1 diabetic cardiomyopath[J]. Biochem Biophys Res Commun,2001,283:549-553.

二级参考文献25

  • 1Lindholm LH, Ibsen H, Borch-Johnsen K, et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens, 2002, 20 : 1879-1886.
  • 2Sever P. The VALUE trial: a commentary. J Renin Angiotensin Aldosterone Syst, 2004, 5:99-101.
  • 3Thurman JM, Schrier RW. Comparative effects of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney. Am J Med, 2003, 114:588-598.
  • 4Naito T, Masaki T, Nikolic-Paterson DJ, et al. Angiotensin Ⅱ induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol, 2004, 286 :F278-287.
  • 5Tokudome T, Horio T, Yoshihara F, et al. Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. Metabolism,2004, 53:710-715.
  • 6Neumann S, Huse K, Semrau R, et al. Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension, 2002, 39:756-760.
  • 7Gray MO, Long CS, Kalinyak JE, et al. Angiotensin Ⅱ stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res, 1998, 40:352-363.
  • 8[1]Karnafel W. Diabetic Cardiomyopathy:Pathophysiology and clinical implications. Przegl Lek, 2000,57 Suppl 4: 9-11
  • 9[2]Yellin,E. L. ,Nikolic,S. ,and Frater,R. W. M. Left ventricular filling dynamics and diastolic function. Cardiovasc. 1990,Dis. 32:247
  • 10[3]Little ,W. C. Enhanced load dependence of relaxation in heart failure :Clinical implications. Circulation 1992,85: 2326

共引文献36

同被引文献123

引证文献10

二级引证文献149

中日友好医院学报
2008年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部